Pfizer partners with Beam Therapeutics to develop rare disease therapies
Beam will receive $300 million in upfront payment and lead research activities till three new therapy targets are selected for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Deals
Exscientia and Sanofi establish research collaboration to develop AI-driven precision engineered…
Exscientia will receive an upfront cash payment of $100 million from Sanofi and will be eligible to receive future research,…
Novo Nordisk completes acquisition of Dicerna Pharmaceuticals
Following the expiration of Novo Nordisk’s cash tender offer for Dicerna, Novo Nordisk has acquired all outstanding shares of…
Piramal Pharma invests Rs 101.77 crores in Hyderabad-based Yapan Bio
The Mumbai-based company has acquired a 27.78 per cent stake in Yapan as a result of the investment
Syngene International announces extension of collaboration with Amgen Contract extended until 2026
Under the extended contract, the dedicated R&D centre, ‘Syngene Amgen Research and Development Center’ (SARC), will continue…
Aragen acquires Intox
Strengthens discovery-to-development integrated platform with the addition of GLP-certified safety assessment capabilities
Cipla to acquire 33 per cent stake in Clean Max Auriga Power
The company will invest up Rs six crores for the 33 per cent stake in the target firm
Fullife Healthcare receives $22 million funding from Morgan Stanley Private Equity Asia
The investment will be instrumental in accelerating the growth of Fast&Up and Chicnutrix brands
Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East
Under the terms of this agreement, Tabuk Pharmaceuticals will hold the marketing authorisation for select speciality products of…
SPARC licenses development and commercialisation rights of PDP-716 and SDN-037 to Visiox Pharma
SPARC to receive equity in Visiox along with other financial considerations
Eris Lifesciences announces Joint Venture with MJ Biopharm to offer insulin in India
The 70:30 Joint Venture will primarily engage in marketing and distribution of human and analogue insulin including Aspart,…
SPARC enters into licensing agreement with Biomodifying to acquire exclusive rights for antibody…
Under the agreement, Biomodifying is eligible for an upfront payment, milestone payments on pre-specified clinical, regulatory,…
Gilead and AWS collaborate on development and delivery of new medicines for patients
With AWS as its preferred cloud provider, Gilead uses AWS machine learning and analytics to better inform clinical trial design…
WuXi STA forms strategic partnership with Coherent Biopharma
According to the agreement, WuXi STA will become the preferred CDMO partner and provide Coherent Biopharma with integrated CMC…
Celltrion signs COVID-19 antibody therapy supply deals with Europe
The first batch of 50,000 doses will be shipped to Europe this year and the company is in talks with 47 other nations including in…
Carlyle partners with Viyash Life Sciences to build generic pharmaceutical platform in India
Carlyle commenced its partnership with Viyash in June 2021, when the company acquired a controlling stake in Symed Labs, a leading…
MedGenome and Emmes launch strategic partnership focussed on advancing rare disease research
During its recognition of Rare Disease Day on 5th March, 2021, the US Food and Drug Administration (FDA) noted, patients with rare…
In talks with MNC pharma companies for acquisition of brands: Bafna Pharma
The city-based company declared its financial results for the quarter ending 30th September, 2021 with standalone net at Rs 2.37…
Masco Group acquires Keyplants AB, a provider of modular life science facilities
The move will strengthen Masco’s leadership in engineering technologies for life sciences
Amneal Pharma acquires injectable firm Punishka Healthcare for Rs 700 crores
The acquisition significantly enhances Amneal’s injectables manufacturing infrastructure, capabilities, and capacity to support…